Methamphetamine in the United States

Methamphetamine in the United States is a significant public health issue, with the drug being classified as a Schedule II controlled substance due to its high potential for abuse and dependency. Methamphetamine, often referred to as meth, is a powerful stimulant that affects the central nervous system and is associated with serious health and social consequences.

History

Methamphetamine was first synthesized in Japan in 1893 from ephedrine. During World War II, it was used by both the Axis and Allied forces for its performance-enhancing effects. In the United States, methamphetamine was first marketed as a nasal decongestant in the 1950s. The Controlled Substances Act of 1970 classified methamphetamine as a Schedule II drug, restricting its availability.

Prevalence

Methamphetamine use in the United States has fluctuated over the years, with significant increases in the 1980s and early 2000s. The National Survey on Drug Use and Health (NSDUH) reported in 2019 that approximately 2 million people in the United States had used methamphetamine in the past year.

Effects on Health

Methamphetamine use can lead to a range of health problems, including psychosis, cardiovascular disease, and neurotoxicity. Long-term use can result in chronic health issues such as cognitive impairment, mental health disorders, and increased risk of infectious diseases like HIV and hepatitis due to risky behaviors associated with drug use.

Legislation and Control

Efforts to control methamphetamine use in the United States have included legislation such as the Combat Methamphetamine Epidemic Act of 2005, which regulates the sale of over-the-counter products containing pseudoephedrine, a key ingredient in the production of methamphetamine.

Treatment

Treatment for methamphetamine addiction often involves a combination of behavioral therapy and support groups. Currently, there are no FDA-approved medications for the treatment of methamphetamine addiction, although research is ongoing.